Literature DB >> 21971889

Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity.

Vivek Bhakta Mathema1, Young-Sang Koh.   

Abstract

Inhibitor of growth-4 (ING4) is a member of the ING family and acts as a tumor suppressor protein. ING4 is a promising candidate for cancer research due to its anti-angiogenic function and its role in the inhibition of cell migration, cell cycle, and induction of apoptosis. Interaction of this protein with the histone acetyl transferase complex plays a vital role in the regulation of multiple nuclear factor kappa light chain enhancer of activated B cells response elements and thus in the regulation of innate immunity. Splice variants of ING4 have different binding affinities to target sites, which results in the enhancement of its functional diversity. ING4 is among the few known regulatory proteins that can directly interact with chromatin as well as with transcription factors. The influence of ING4 on tumor necrosis factor-α, keratinocyte chemoattractant, interleukin (IL)-6, IL-8, matrix metalloproteinases, cyclooxygenase-2, and IκBα expression clearly demonstrates its critical role in the regulation of inflammatory mediators. Its interaction with liprin α1 and p53 contribute to mitigate cell spreading and induce apoptosis of cancer cells. Multiple factors including breast cancer melanoma suppressor-1 are upstream regulators of ING4 and are frequently deactivated in tumor cells. In the present review, the different properties of ING4 are discussed, and its activities are correlated with different aspects of cell physiology. Special emphasis is placed on our current understanding of ING4 with respect to its influence on chromatin modification, tumorigenesis, and innate immunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971889     DOI: 10.1007/s13277-011-0249-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  68 in total

Review 1.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 2.  Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4.

Authors:  Abdullah Ozer; Richard K Bruick
Journal:  Cell Cycle       Date:  2005-09-19       Impact factor: 4.534

Review 3.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

4.  EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells.

Authors:  Cécile Le Page; Ismael Hervé Koumakpayi; Laurent Lessard; Anne-Marie Mes-Masson; Fred Saad
Journal:  Prostate       Date:  2005-10-01       Impact factor: 4.104

5.  Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients.

Authors:  Anjali S Advani; Sarah E Gibson; Elizabeth Douglas; Tao Jin; Xiaoxian Zhao; Matt Kalaycio; Ed Copelan; Ronald Sobecks; Mikkael Sekeres; Shawnda Sungren; Eric D Hsi
Journal:  BMC Cancer       Date:  2010-07-21       Impact factor: 4.430

6.  The sponge/Matrigel angiogenesis assay.

Authors:  Nasim Akhtar; Erin B Dickerson; Robert Auerbach
Journal:  Angiogenesis       Date:  2002       Impact factor: 9.596

Review 7.  Nuclear factor-kappa B: from clone to clinic.

Authors:  Kwang Seok Ahn; Gautam Sethi; Bharat B Aggarwal
Journal:  Curr Mol Med       Date:  2007-11       Impact factor: 2.222

Review 8.  p53 polymorphisms: cancer implications.

Authors:  Catherine Whibley; Paul D P Pharoah; Monica Hollstein
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

9.  EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.

Authors:  Abhik Saha; Adebowale Bamidele; Masanao Murakami; Erle S Robertson
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

10.  Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.

Authors:  Xiufen Lei; Zhiqiang Bai; Fengchun Ye; Jianping Xie; Chan-Gil Kim; Yufei Huang; Shou-Jiang Gao
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

View more
  7 in total

1.  MicroRNA-650 in a copy number-variable region regulates the production of interleukin 6 in human osteosarcoma cells.

Authors:  Jun Ho Yun; Sanghoon Moon; Heun-Sik Lee; Mi Yeong Hwang; Yeon-Jung Kim; Ho-Yeong Yu; Youngsoo Kim; Bok-Ghee Han; Bong-Jo Kim; Jeong-Min Kim
Journal:  Oncol Lett       Date:  2015-08-07       Impact factor: 2.967

Review 2.  Inhibitor of growth-4 is a potential target for cancer therapy.

Authors:  Shuping Yuan; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  Tumour Biol       Date:  2016-01-23

3.  Reduced expression and prognostic implication of inhibitor of growth 4 in human osteosarcoma.

Authors:  Dahang Zhao; Xiangjie Liu; Yunge Zhang; Zhaoming Ding; Feng Dong; Hongwei Xu; Baoxin Wang; Wenbo Wang
Journal:  Oncol Lett       Date:  2016-03-09       Impact factor: 2.967

4.  MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression.

Authors:  Jia-Yuan Huang; Shi-Yun Cui; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Bing Feng; Ming Sun; Wei De; Rui Wang; Long-Bang Chen
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

5.  Novel multiple markers to distinguish melanoma from dysplastic nevi.

Authors:  Guohong Zhang; Gang Li
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

6.  Staphylococcus aureus Esx Factors Control Human Dendritic Cell Functions Conditioning Th1/Th17 Response.

Authors:  Melania Cruciani; Marilena P Etna; Romina Camilli; Elena Giacomini; Zulema A Percario; Martina Severa; Silvia Sandini; Fabiana Rizzo; Valentina Brandi; Giuliana Balsamo; Fabio Polticelli; Elisabetta Affabris; Annalisa Pantosti; Fabio Bagnoli; Eliana M Coccia
Journal:  Front Cell Infect Microbiol       Date:  2017-07-21       Impact factor: 5.293

7.  Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.

Authors:  Jiajin Yang; Heng Ge; Caroline J Poulton; Susan L Hogan; Yichun Hu; Britta E Jones; Candace D Henderson; Elizabeth A McInnis; William F Pendergraft; J Charles Jennette; Ronald J Falk; Dominic J Ciavatta
Journal:  Clin Epigenetics       Date:  2016-08-12       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.